a public good project by the
Synthesis
Company
of California

© 2026

Scott Van Wart | doi.page

0 works0 citations0 h-index

Scott Van Wart

Institute for Clinical Pharmacodynamics (United States)(US)AngioDynamics (United States)(US)

Publications by Year

Research Areas

Antibiotics Pharmacokinetics and Efficacy, Monoclonal and Polyclonal Antibodies Research, Pneumonia and Respiratory Infections, Antibiotic Resistance in Bacteria, Antifungal resistance and susceptibility

Most-Cited Works

→ Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue(2015)226 cited
→ Pharmacokinetics and Leukocyte Responses of Recombinant Human Interleukin-10(1998)72 cited
→ Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival(2015)59 cited
→ Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study(2021)55 cited
→ Population Pharmacokinetics and Pharmacodynamics of Garenoxacin in Patients with Community-Acquired Respiratory Tract Infections(2004)48 cited
→ Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN)(2020)45 cited

→ Use of Pharmacodynamic End Points in the Evaluation of Gatifloxacin for the Treatment of Acute Maxillary Sinusitis(2004)

39 cited

→ A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics(2019)13 cited

→ Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy(2021)12 cited

→ A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function(2018)12 cited